Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 3
1962 1
1963 3
1964 1
1966 1
1967 2
1968 2
1969 3
1970 2
1971 2
1972 7
1973 6
1974 3
1975 6
1976 5
1977 6
1978 3
1979 1
1980 6
1981 5
1982 7
1983 11
1984 12
1985 11
1986 7
1987 13
1988 17
1989 18
1990 12
1991 14
1992 13
1993 24
1994 31
1995 41
1996 26
1997 26
1998 27
1999 24
2000 38
2001 31
2002 39
2003 31
2004 54
2005 43
2006 36
2007 41
2008 42
2009 43
2010 45
2011 66
2012 62
2013 55
2014 80
2015 66
2016 96
2017 89
2018 87
2019 89
2020 78
2021 86
2022 130
2023 119
2024 38

Text availability

Article attribute

Article type

Publication date

Search Results

1,821 results

Results by year

Filters applied: . Clear all
Page 1
A circulating subset of iNKT cells mediates antitumor and antiviral immunity.
Cui G, Shimba A, Jin J, Ogawa T, Muramoto Y, Miyachi H, Abe S, Asahi T, Tani-Ichi S, Dijkstra JM, Iwamoto Y, Kryukov K, Zhu Y, Takami D, Hara T, Kitano S, Xu Y, Morita H, Zhang M, Zreka L, Miyata K, Kanaya T, Okumura S, Ito T, Hatano E, Takahashi Y, Watarai H, Oike Y, Imanishi T, Ohno H, Ohteki T, Minato N, Kubo M, Holländer GA, Ueno H, Noda T, Shiroguchi K, Ikuta K. Cui G, et al. Among authors: miyata k. Sci Immunol. 2022 Oct 28;7(76):eabj8760. doi: 10.1126/sciimmunol.abj8760. Epub 2022 Oct 21. Sci Immunol. 2022. PMID: 36269840 Free article.
Morgagnian Cataract.
Ono T, Miyata K. Ono T, et al. Among authors: miyata k. JMA J. 2022 Jul 15;5(3):379-380. doi: 10.31662/jmaj.2022-0077. Epub 2022 Jun 24. JMA J. 2022. PMID: 35992280 Free PMC article. No abstract available.
Reply.
Ono T, Mori Y, Minami K, Miyata K. Ono T, et al. Among authors: miyata k. Cornea. 2021 Mar 1;40(3):e7. doi: 10.1097/ICO.0000000000002630. Cornea. 2021. PMID: 33332895 No abstract available.
Targeting DHX9 Triggers Tumor-Intrinsic Interferon Response and Replication Stress in Small Cell Lung Cancer.
Murayama T, Nakayama J, Jiang X, Miyata K, Morris AD, Cai KQ, Prasad RM, Ma X, Efimov A, Belani N, Gerstein ER, Tan Y, Zhou Y, Kim W, Maruyama R, Campbell KS, Chen L, Yang Y, Balachandran S, Cañadas I. Murayama T, et al. Among authors: miyata k. Cancer Discov. 2024 Mar 1;14(3):468-491. doi: 10.1158/2159-8290.CD-23-0486. Cancer Discov. 2024. PMID: 38189443 Free PMC article.
Association Between Statin Use and Daptomycin-related Musculoskeletal Adverse Events: A Mixed Approach Combining a Meta-analysis and a Disproportionality Analysis.
Chuma M, Nakamoto A, Bando T, Niimura T, Kondo Y, Hamano H, Okada N, Asada M, Zamami Y, Takechi K, Goda M, Miyata K, Yagi K, Yoshioka T, Izawa-Ishizawa Y, Yanagawa H, Tasaki Y, Ishizawa K. Chuma M, et al. Among authors: miyata k. Clin Infect Dis. 2022 Oct 12;75(8):1416-1422. doi: 10.1093/cid/ciac128. Clin Infect Dis. 2022. PMID: 35262686 Free PMC article.
Preface: A new era of RNA-based therapies.
Hwa Kim S, Miyata K. Hwa Kim S, et al. Among authors: miyata k. Adv Drug Deliv Rev. 2024 Feb;205:115162. doi: 10.1016/j.addr.2023.115162. Epub 2023 Dec 20. Adv Drug Deliv Rev. 2024. PMID: 38135058 No abstract available.
1,821 results